Large-scale testing (Phase 3)Study completedNCT04047173What this trial is testingRFA Versus SBRT for Recurrent Small HCCWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 166
Testing effectiveness (Phase 2)Ended earlyNCT05497453What this trial is testingEvaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC OncogeneWho this might be right forHepatocellular CarcinomaSolid TumorHepatocellular Carcinoma Non-resectable+4 more Omega Therapeutics 24
Early research (Phase 1)Study completedNCT02143401What this trial is testingNavitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid TumorsWho this might be right forCirrhosisHepatitis B InfectionHepatitis C Infection+6 more National Cancer Institute (NCI) 29
Early research (Phase 1)UnknownNCT05352646What this trial is testingNewishT Cell Therapy for HCC With High Risk of Recurrence After Radical ResectionWho this might be right forHepatocellular Carcinoma Newish Technology (Beijing) Co., Ltd. 26
Testing effectiveness (Phase 2)UnknownNCT04834986What this trial is testingTislelizumab Combined With Lenvatinib for Perioperative Treatment of Resectable Primary Hepatocellular CarcinomaWho this might be right forResectable Hepatocellular Carcinoma Tianjin Medical University Cancer Institute and Hospital 30
Post-approval studies (Phase 4)Looking for participantsNCT07405086What this trial is testingMorning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyWho this might be right forAdvanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more OHSU Knight Cancer Institute 160
Large-scale testing (Phase 3)UnknownNCT04682210What this trial is testingSintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative ResectionWho this might be right forHCCAdjuvant TherapyImmunotherapy Sun Yat-sen University 246
Not applicableUnknownNCT02813096What this trial is testingStudy of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT PatientsWho this might be right forCarcinoma, Hepatocellular Guangxi Medical University 500
Not applicableStudy completedNCT00822562What this trial is testingResearch on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver CancerWho this might be right forHepatocellular Carcinoma Eastern Hepatobiliary Surgery Hospital 100
Early research (Phase 1)Study completedNCT01075113What this trial is testingSorafenib and Vorinostat in Treating Patients With Advanced Liver CancerWho this might be right forLiver Cancer Virginia Commonwealth University 16
Not applicableNot Yet RecruitingNCT07350824What this trial is testingPredictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCCWho this might be right forHCCMinimal Residual DiseaseRecurrence Tongji Hospital 276
Large-scale testing (Phase 3)UnknownNCT03192618What this trial is testingThe Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.Who this might be right forHepatocellular Carcinoma Sun Yat-sen University 290
Testing effectiveness (Phase 2)Looking for participantsNCT04803318What this trial is testingTrametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid TumorsWho this might be right forSolid Tumor, AdultHepatocellular Carcinoma Second Affiliated Hospital of Guangzhou Medical University 100
Large-scale testing (Phase 3)UnknownNCT04237740What this trial is testingRelenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver TransplantationWho this might be right forHepatocellular CarcinomaLiver Transplantation RenJi Hospital 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04639180What this trial is testingEvaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or AblationWho this might be right forHepatocellular Carcinoma (HCC) Jiangsu HengRui Medicine Co., Ltd. 687
Not applicableActive Not RecruitingNCT07009470What this trial is testingA Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for RecurrenceWho this might be right forHCC Tongji Hospital 130
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06409637What this trial is testingFOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver TransplantationWho this might be right forLiver CancerLiver Transplant Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 62
Not applicableLooking for participantsNCT06236568What this trial is testingImpact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver TransplantationWho this might be right forHepatocellular CarcinomaLiver Transplant; Complications Azienda Ospedaliero-Universitaria di Modena 40
Not applicableUnknownNCT05458115What this trial is testingClinical Study of MRD Recurrence Monitoring After Surgical Resection of Hepatocellular CarcinomaWho this might be right forHCC Anhui Provincial Hospital 200
Early research (Phase 1)Study completedNCT00005860What this trial is testingOxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumWho this might be right forCancer Memorial Sloan Kettering Cancer Center